Managing the Oral Side-Effects of Medications Used to Treat Multiple Sclerosis

Australian Dental Journal - United States
doi 10.1111/adj.12510
Full Text
Abstract

Available in full text

Categories
Dentistry
Date
Authors
Publisher

Wiley

Related search

Siponimod: A New Approved Oral Drug to Treat Multiple Sclerosis

NeuroPharmac Journal
2019English

Multiple Sclerosis in 2015: Managing the Complexity of Multiple Sclerosis

Nature Reviews Neurology
Molecular NeuroscienceNeurologyCellular
2016English

Targeting Dendritic Cells to Treat Multiple Sclerosis

Nature Reviews Neurology
Molecular NeuroscienceNeurologyCellular
2010English

Angioplasty Used to Treat Multiple Sclerosis Patients: A Potential Revolution in Health Care Technology

Revue interdisciplinaire des sciences de la santé - Interdisciplinary Journal of Health Sciences
2011English

Molecular Pharmacodynamics of New Oral Drugs Used in the Treatment of Multiple Sclerosis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2014English

Managing the Side Effects of Invasion Control

Science
MultidisciplinaryPhilosophy of ScienceHistory
2014English

Managing Neuropsychological Impairment in Multiple Sclerosis

International Journal of MS Care
NeurologySpecialized NursingAdvanced
2015English

Novel Medications to Treat Addictive Disorders

Current Psychiatry Reports
PsychiatryMental Health
2008English

Managing Multiple Sclerosis: Treatment Initiation, Modification, and Sequencing

Canadian Journal of Neurological Sciences
MedicineNeurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy